Alzamend Neuro, Inc. SEC filings ALZN

Alzamend Neuro, Inc. has 397 filings in SEC EDGAR's recent list, going back to Jun 22, 2016. Its latest annual report, Form 10-K, was filed on Jul 22, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 10, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (regulation fd disclosure). The company's fiscal year ends on April 30.

Form Description Filed Period
10-Q Quarterly report Sep 10, 2026 Jul 31, 2026
10-Q Quarterly report Mar 11, 2026 Jan 31, 2026
10-Q Quarterly report Dec 9, 2025 Oct 31, 2025
10-Q Quarterly report Sep 10, 2025 Jul 31, 2025
10-Q Quarterly report Mar 10, 2025 Jan 31, 2025
10-Q Quarterly report Dec 11, 2024 Oct 31, 2024
10-Q Quarterly report Sep 11, 2024 Jul 31, 2024
10-Q Quarterly report Mar 25, 2024 Jan 31, 2024
10-Q Quarterly report Dec 15, 2023 Oct 31, 2023
10-Q Quarterly report Sep 13, 2023 Jul 31, 2023
10-Q Quarterly report Mar 15, 2023 Jan 31, 2023
10-Q Quarterly report Dec 12, 2022 Oct 31, 2022
10-Q Quarterly report Sep 13, 2022 Jul 31, 2022
10-Q Quarterly report Mar 15, 2022 Jan 31, 2022
10-Q Quarterly report Dec 13, 2021 Oct 31, 2021
10-Q Quarterly report Sep 13, 2021 Jul 31, 2021

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ALZN (Nasdaq)
Fiscal year ends
April 30
Incorporated in
DE
Headquarters
Atlanta, GA
SEC filer status
, Emerging growth company
SEC CIK
1677077

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.